GlassScriptPhysician profile
Jennifer Diaz
NPI 1013518711
$3,018.29
in general payments reported to CMS, 2019-2025
18 companies · $1,220 in 2025
The $1,220 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.18 · 2022: $296 · 2023: $423 · 2024: $1,061 · 2025: $1,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,703.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $721.04 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $669.90 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $454.62 | 2024-2025 | Repatha, Evenity, Prolia |
| Lilly USA, LLC | $253.01 | 2021-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $146.00 | 2022-2025 | Jardiance, Synjardy |
| Axsome Therapeutics, INC. | $122.84 | 2024 | Auvelity |
| Abbvie INC. | $110.43 | 2025 | |
| Ardelyx, INC. | $79.04 | 2025 | Ibsrela |
| Bayer Healthcare Pharmaceuticals INC. | $74.54 | 2023-2025 | |
| Radius Health, INC. | $72.15 | 2025 | Tymlos |
| Pfizer INC. | $65.33 | 2025 | |
| Jazz Pharmaceuticals INC. | $56.65 | 2025 | |
| Stryker Corporation | $38.62 | 2023 | Stryker |
| Glaxosmithkline, LLC. | $37.62 | 2025 | Trelegy Ellipta |
| Exact Sciences Corporation | $36.91 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $28.94 | 2024 | |
| Eisai INC. | $27.58 | 2025 | |
| Corcept Therapeutics | $23.07 | 2025 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.